Marvin Guinyu Chang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Coagulation Disorders | 2 | 2021 | 337 | 1.240 |
Why?
|
Point-of-Care Systems | 5 | 2024 | 1177 | 1.190 |
Why?
|
Pneumonia, Viral | 10 | 2021 | 3240 | 1.150 |
Why?
|
Coronavirus Infections | 9 | 2020 | 3133 | 1.100 |
Why?
|
Intubation, Intratracheal | 3 | 2023 | 1364 | 1.010 |
Why?
|
Arrhythmias, Cardiac | 7 | 2021 | 2268 | 0.760 |
Why?
|
Ultrasonography | 6 | 2023 | 5985 | 0.690 |
Why?
|
Electroconvulsive Therapy | 1 | 2024 | 477 | 0.660 |
Why?
|
Pandemics | 10 | 2021 | 8388 | 0.620 |
Why?
|
Equipment and Supplies | 1 | 2020 | 281 | 0.610 |
Why?
|
Thrombosis | 2 | 2021 | 2968 | 0.580 |
Why?
|
Myocytes, Cardiac | 6 | 2021 | 1637 | 0.550 |
Why?
|
Critical Illness | 6 | 2021 | 2670 | 0.520 |
Why?
|
Thromboembolism | 1 | 2021 | 986 | 0.510 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7279 | 0.480 |
Why?
|
Action Potentials | 7 | 2021 | 1806 | 0.470 |
Why?
|
Heart Arrest | 1 | 2024 | 1470 | 0.470 |
Why?
|
Pinacidil | 1 | 2012 | 10 | 0.450 |
Why?
|
KATP Channels | 1 | 2012 | 45 | 0.440 |
Why?
|
Heart Conduction System | 3 | 2012 | 1047 | 0.400 |
Why?
|
Heart Ventricles | 5 | 2021 | 3821 | 0.390 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2021 | 789 | 0.370 |
Why?
|
Heart-Assist Devices | 1 | 2019 | 1194 | 0.340 |
Why?
|
Echocardiography | 1 | 2020 | 5102 | 0.300 |
Why?
|
Airway Management | 2 | 2020 | 329 | 0.280 |
Why?
|
Anticoagulants | 1 | 2021 | 4599 | 0.270 |
Why?
|
Tachycardia, Ventricular | 2 | 2011 | 1273 | 0.240 |
Why?
|
Nitric Oxide | 3 | 2023 | 2132 | 0.240 |
Why?
|
Respiratory Insufficiency | 2 | 2023 | 1199 | 0.230 |
Why?
|
Lung | 2 | 2020 | 9856 | 0.210 |
Why?
|
Milrinone | 1 | 2021 | 84 | 0.200 |
Why?
|
Dobutamine | 1 | 2021 | 123 | 0.200 |
Why?
|
Torsades de Pointes | 2 | 2012 | 78 | 0.200 |
Why?
|
Voltage-Sensitive Dye Imaging | 2 | 2011 | 31 | 0.190 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2006 | 496 | 0.190 |
Why?
|
Calcium Channels, L-Type | 2 | 2012 | 240 | 0.170 |
Why?
|
Rats | 7 | 2021 | 24260 | 0.170 |
Why?
|
Wound Healing | 1 | 2009 | 2785 | 0.160 |
Why?
|
Tomography | 1 | 2020 | 390 | 0.160 |
Why?
|
Pulmonary Ventilation | 1 | 2020 | 373 | 0.160 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Acetaminophen | 1 | 2021 | 545 | 0.150 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2020 | 274 | 0.140 |
Why?
|
Humans | 29 | 2024 | 744343 | 0.140 |
Why?
|
Electric Impedance | 1 | 2020 | 729 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.140 |
Why?
|
Esophagus | 1 | 2022 | 1019 | 0.140 |
Why?
|
Animals, Newborn | 3 | 2012 | 2726 | 0.130 |
Why?
|
Models, Biological | 1 | 2012 | 9583 | 0.130 |
Why?
|
Heart Failure | 1 | 2019 | 10900 | 0.130 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2021 | 581 | 0.130 |
Why?
|
Drug Monitoring | 1 | 2021 | 956 | 0.130 |
Why?
|
Administration, Inhalation | 3 | 2023 | 1105 | 0.130 |
Why?
|
Connexin 43 | 2 | 2006 | 207 | 0.120 |
Why?
|
Respiration | 1 | 2021 | 1653 | 0.120 |
Why?
|
Enteral Nutrition | 1 | 2020 | 763 | 0.120 |
Why?
|
Device Removal | 1 | 2019 | 656 | 0.120 |
Why?
|
Heparin | 1 | 2021 | 1637 | 0.120 |
Why?
|
Hemodynamics | 1 | 2024 | 4199 | 0.120 |
Why?
|
Infection Control | 1 | 2020 | 966 | 0.110 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 2012 | 36 | 0.110 |
Why?
|
Heart | 2 | 2020 | 4467 | 0.110 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2023 | 1354 | 0.110 |
Why?
|
Isoproterenol | 1 | 2012 | 399 | 0.100 |
Why?
|
Electric Conductivity | 1 | 2012 | 411 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2158 | 0.100 |
Why?
|
Seizures | 1 | 2024 | 2859 | 0.100 |
Why?
|
Body Surface Potential Mapping | 1 | 2012 | 238 | 0.100 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.090 |
Why?
|
Calcium | 2 | 2021 | 5756 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.090 |
Why?
|
Calcium Channel Blockers | 2 | 2010 | 690 | 0.090 |
Why?
|
Hemorrhage | 1 | 2021 | 3461 | 0.090 |
Why?
|
Potassium Channel Blockers | 1 | 2009 | 171 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1479 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2026 | 0.080 |
Why?
|
Anesthesia | 1 | 2020 | 1561 | 0.080 |
Why?
|
Emergency Medical Services | 1 | 2020 | 1917 | 0.080 |
Why?
|
Atrioventricular Block | 1 | 2010 | 120 | 0.080 |
Why?
|
Ventricular Fibrillation | 1 | 2011 | 538 | 0.080 |
Why?
|
Sodium Channel Blockers | 1 | 2009 | 176 | 0.080 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2009 | 555 | 0.080 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11727 | 0.080 |
Why?
|
Random Allocation | 1 | 2012 | 2429 | 0.080 |
Why?
|
Sodium Channels | 1 | 2009 | 349 | 0.080 |
Why?
|
Electric Stimulation | 1 | 2012 | 1767 | 0.080 |
Why?
|
Organ Culture Techniques | 1 | 2009 | 813 | 0.070 |
Why?
|
Respiration, Artificial | 3 | 2023 | 2569 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2012 | 19229 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2006 | 1341 | 0.060 |
Why?
|
Hospitalization | 2 | 2021 | 10262 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15226 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.060 |
Why?
|
Animals | 8 | 2021 | 168757 | 0.060 |
Why?
|
Myoblasts | 1 | 2005 | 238 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 2 | 2012 | 8301 | 0.060 |
Why?
|
Electrophysiology | 1 | 2006 | 1308 | 0.050 |
Why?
|
Aged | 4 | 2024 | 163280 | 0.050 |
Why?
|
Gastrointestinal Diseases | 2 | 2020 | 1170 | 0.050 |
Why?
|
Adult | 4 | 2024 | 214055 | 0.050 |
Why?
|
Myocardial Contraction | 1 | 2006 | 1585 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.050 |
Why?
|
Intestinal Absorption | 1 | 2021 | 420 | 0.040 |
Why?
|
Single-Blind Method | 1 | 2023 | 1590 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 1678 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 535 | 0.040 |
Why?
|
Endocrine System Diseases | 1 | 2020 | 248 | 0.040 |
Why?
|
Epinephrine | 1 | 2021 | 792 | 0.040 |
Why?
|
Ventilators, Mechanical | 1 | 2020 | 292 | 0.040 |
Why?
|
Male | 5 | 2024 | 350118 | 0.040 |
Why?
|
Electrocardiography | 1 | 2011 | 6442 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6196 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 56430 | 0.040 |
Why?
|
Intensive Care Units | 2 | 2021 | 3679 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14722 | 0.040 |
Why?
|
Brain | 1 | 2024 | 26385 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2021 | 591 | 0.040 |
Why?
|
Female | 5 | 2024 | 380194 | 0.040 |
Why?
|
Hematologic Diseases | 1 | 2020 | 498 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 72290 | 0.040 |
Why?
|
Shock, Cardiogenic | 1 | 2021 | 688 | 0.030 |
Why?
|
Biofilms | 1 | 2020 | 617 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 1 | 2006 | 1632 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 612 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.030 |
Why?
|
Rabbits | 1 | 2021 | 4894 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 722 | 0.030 |
Why?
|
Musculoskeletal Diseases | 1 | 2020 | 581 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18029 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1162 | 0.030 |
Why?
|
Skin Diseases | 1 | 2020 | 1065 | 0.030 |
Why?
|
Heart Transplantation | 1 | 2005 | 3110 | 0.030 |
Why?
|
Nutritional Status | 1 | 2020 | 1609 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1622 | 0.020 |
Why?
|
Nifedipine | 1 | 2010 | 226 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4931 | 0.020 |
Why?
|
Obesity | 2 | 2023 | 12745 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 213383 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2020 | 2149 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2021 | 10943 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 40075 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2010 | 1137 | 0.020 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2007 | 194 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2010 | 2505 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7322 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29144 | 0.020 |
Why?
|
Lidocaine | 1 | 2007 | 544 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13989 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9959 | 0.020 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2007 | 845 | 0.010 |
Why?
|
Potassium | 1 | 2007 | 1336 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2007 | 1534 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3582 | 0.010 |
Why?
|
HeLa Cells | 1 | 2005 | 3128 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53288 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15165 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 63114 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81183 | 0.000 |
Why?
|